Choi, Yong Mi https://orcid.org/0000-0002-5776-3602
Ajjaji, Dalila
Fleming, Kaelin D. https://orcid.org/0000-0003-3063-7865
Borbat, Peter P.
Jenkins, Meredith L.
Moeller, Brandon E.
Fernando, Shaveen https://orcid.org/0000-0001-9240-6531
Bhatia, Surita R. https://orcid.org/0000-0002-5950-193X
Freed, Jack H. https://orcid.org/0000-0003-4288-2585
Burke, John E. https://orcid.org/0000-0001-7904-9859
Thiam, Abdou Rachid https://orcid.org/0000-0001-7488-4724
Airola, Michael V. https://orcid.org/0000-0003-4981-1253
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35128666, 1R24GM146107, P41GM103521)
Alfred P. Sloan Foundation
National Science Foundation (CBET 1903189, DGE 1922639)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (Discovery Grant 2020-04241)
Michael Smith Foundation for Health Research (Scholar award 17868)
Agence Nationale de la Recherche (CE11-0032-02-LIPRODYN, 21-CE13-0014-LIPDROPER)
Article History
Received: 2 November 2022
Accepted: 12 May 2023
First Online: 2 June 2023
Competing interests
: JEB reports personal fees from Scorpion Therapeutics and Olema Oncology; and research grants from Novartis. The remaining authors declare no competing interests.